Given that TREM2 was found to play a protective role in hepatocarcinogenesis in a mouse model, we hypothesize that TREM2+ LAM-like cells are a double-edged sword: they restrict inflammatory injury and tumorigenesis in the early stage but suppress the antitumor immune response and promote cancer progression in the later period. Here, TREM2 is linked to cancer.